Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
12Jan2026
  • Home
  • About
  • News
  • Subscribe
12Jan2026
Cost Curve NewsCost Curve News
Cost Curve News

340B Can Be Hard to Parse. Especially for AI

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
9 months ago
Keep Reading
Cost Curve News

Here’s the Math Behind the Idea that IRA ‘Negotiations’ Will Kill Early-Stage Programs

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
9 months ago
Keep Reading
Cost Curve News

Is a New Trend — Phony Pharm to Table — Emerging?

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
9 months ago
Keep Reading
Cost Curve News

A Bigger, Better Future Is Coming for Cost Curve

I don’t have anything insightful or novel to say about the HHS firings today, but I can’t let the moment go unacknowledged. None of this is good, as evidenced by
10 months ago
Keep Reading
Cost Curve News

Pfizer Goes Deep on the Hows and Whys of the $1 Billion Part D Redesign Impact

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
10 months ago
Keep Reading
Cost Curve News

LillyDirect Adds Neurology to Its Pharm to Table Platform

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
10 months ago
Keep Reading
Cost Curve News

Pharma Is Investing in Innovation at a Record Rate (And Other Trends from an Awesome New IQVIA Report)

For fans of 340B and/or “Where’s Waldo”: I’ve hidden a single 340B reference in this newsletter. Can you find it? INFLECTION POINT/ IQVIA Quantifies Innovation … And Points to Some
10 months ago
Keep Reading
Cost Curve News

A Big PBM Says the Price of Drugs Is Accelerating (But Other Industry Data Points in the Opposite Direction)

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
10 months ago
Keep Reading
Cost Curve News

Novo’s Latest Move Shines More Light on How It’s Structuring ‘Pharm to Table’

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
10 months ago
Keep Reading
Cost Curve News

Another Day, Another Example of 340B Abuse Featured in a National Newspaper

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
10 months ago
Keep Reading
181920

Latest Posts

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

January 9, 2026

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

January 8, 2026

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

January 7, 2026

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

January 6, 2026

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

January 5, 2026

Popular

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (3,075)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,266)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (2,016)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,826)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,817)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

January 9, 2026

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

January 8, 2026

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2026 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe